
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Recipient : Syntekabio
Deal Size : Undisclosed
Deal Type : Partnership
Syntekabio and Enamine partner for AI-based drug development
Details : The alliance will leverage an extensive synthetic compound library provided by Enamine to support drug candidate discovery services through Syntekabio’s AI platform, DeepMatcher.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 03, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Recipient : Syntekabio
Deal Size : Undisclosed
Deal Type : Partnership
